RIYADH: Saudi Arabia’s King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed its first allogeneic stem cell transplant for a patient diagnosed with acute myeloid leukemia — marking a significant medical milestone for the region.
“This advanced medical step enables patients with complex blood disorders in Madinah and the surrounding areas to receive highly specialised treatment close to their families,” KFSHRC stated in a press release on Thursday.
“The achievement was made possible through the collaboration of multidisciplinary teams across the hospital, who convened from the earliest stages to establish a comprehensive plan.”
The hospital said the collaborative role played by clinical, nursing, and laboratory teams in managing the complexity of the procedure.
Stem cell transplantation is considered one of the most advanced and challenging medical treatments globally.
It involves replacing diseased bone marrow with healthy stem cells from a compatible donor, and is commonly used to treat serious conditions such as leukemia, bone marrow failure, and certain immune disorders.
KFSHRC Madinah currently operates with 400 beds and offers specialised services across a range of fields, including adult and pediatric oncology, ophthalmology, and obstetrics and gynecology.
The hospital has also received 14 training accreditations in various medical and nursing specialties.
Further highlighting its reputation for excellence, King Faisal Specialist Hospital has been ranked first in the Middle East and Africa, and 15th globally, among the world’s top 250 academic medical centers for 2025.
